155 related articles for article (PubMed ID: 35284037)
1. Cytogenetic and molecular analyses of 291 gastrointestinal stromal tumors: site-specific cytogenetic evolution as evidence of pathogenetic heterogeneity.
Gorunova L; Boye K; Panagopoulos I; Berner JM; Bjerkehagen B; Hompland I; Lobmaier I; Hølmebakk T; Hveem TS; Heim S; Micci F
Oncotarget; 2022; 13():508-517. PubMed ID: 35284037
[TBL] [Abstract][Full Text] [Related]
2. Array CGH analysis in primary gastrointestinal stromal tumors: cytogenetic profile correlates with anatomic site and tumor aggressiveness, irrespective of mutational status.
Wozniak A; Sciot R; Guillou L; Pauwels P; Wasag B; Stul M; Vermeesch JR; Vandenberghe P; Limon J; Debiec-Rychter M
Genes Chromosomes Cancer; 2007 Mar; 46(3):261-76. PubMed ID: 17171690
[TBL] [Abstract][Full Text] [Related]
3. Chromosomal aberrations in primary PDGFRA-mutated gastrointestinal stromal tumors.
Schaefer IM; Delfs C; Cameron S; Gunawan B; Agaimy A; Ghadimi BM; Haller F
Hum Pathol; 2014 Jan; 45(1):85-97. PubMed ID: 24157063
[TBL] [Abstract][Full Text] [Related]
4. Hereditary gastrointestinal stromal tumors sharing the KIT Exon 17 germline mutation p.Asp820Tyr develop through different cytogenetic progression pathways.
Veiga I; Silva M; Vieira J; Pinto C; Pinheiro M; Torres L; Soares M; Santos L; Duarte H; Bastos AL; Coutinho C; Dinis J; Lopes C; Teixeira MR
Genes Chromosomes Cancer; 2010 Feb; 49(2):91-8. PubMed ID: 19847891
[TBL] [Abstract][Full Text] [Related]
5. Chromosome copy number changes carry prognostic information independent of KIT/PDGFRA point mutations in gastrointestinal stromal tumors.
Silva M; Veiga I; Ribeiro FR; Vieira J; Pinto C; Pinheiro M; Mesquita B; Santos C; Soares M; Dinis J; Santos L; Lopes P; Afonso M; Lopes C; Teixeira MR
BMC Med; 2010 May; 8():26. PubMed ID: 20470368
[TBL] [Abstract][Full Text] [Related]
6. Rhabdoid morphology in gastrointestinal stromal tumours (GISTs) is associated with PDGFRA mutations but does not imply aggressive behaviour.
Schaefer IM; Ströbel P; Cameron S; Beham A; Otto C; Schildhaus HU; Agaimy A
Histopathology; 2014 Feb; 64(3):421-30. PubMed ID: 24266839
[TBL] [Abstract][Full Text] [Related]
7. Genetic aberrations of gastrointestinal stromal tumors.
Yang J; Du X; Lazar AJ; Pollock R; Hunt K; Chen K; Hao X; Trent J; Zhang W
Cancer; 2008 Oct; 113(7):1532-43. PubMed ID: 18671247
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal stromal tumors - Summary of mutational status of the primary/secondary KIT/PDGFRA mutations, BRAF mutations and SDH defects.
Kalfusova A; Linke Z; Kalinova M; Krskova L; Hilska I; Szabova J; Vicha A; Kodet R
Pathol Res Pract; 2019 Dec; 215(12):152708. PubMed ID: 31708372
[TBL] [Abstract][Full Text] [Related]
9. Neurofibromatosis type 1-related gastrointestinal stromal tumors: a special reference to loss of heterozygosity at 14q and 22q.
Yamamoto H; Tobo T; Nakamori M; Imamura M; Kojima A; Oda Y; Nakamura N; Takahira T; Yao T; Tsuneyoshi M
J Cancer Res Clin Oncol; 2009 Jun; 135(6):791-8. PubMed ID: 19020900
[TBL] [Abstract][Full Text] [Related]
10. Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors.
Janeway KA; Liegl B; Harlow A; Le C; Perez-Atayde A; Kozakewich H; Corless CL; Heinrich MC; Fletcher JA
Cancer Res; 2007 Oct; 67(19):9084-8. PubMed ID: 17909012
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
Miettinen M; Sobin LH; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
[TBL] [Abstract][Full Text] [Related]
12. Detection of mutations in the BRAF gene in patients with KIT and PDGFRA wild-type gastrointestinal stromal tumors.
Jasek K; Buzalkova V; Minarik G; Stanclova A; Szepe P; Plank L; Lasabova Z
Virchows Arch; 2017 Jan; 470(1):29-36. PubMed ID: 27864688
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events.
Huss S; Pasternack H; Ihle MA; Merkelbach-Bruse S; Heitkötter B; Hartmann W; Trautmann M; Gevensleben H; Büttner R; Schildhaus HU; Wardelmann E
Hum Pathol; 2017 Apr; 62():206-214. PubMed ID: 28159677
[TBL] [Abstract][Full Text] [Related]
14. Concomitant KIT/BRAF and PDGFRA/BRAF mutations are rare events in gastrointestinal stromal tumors.
Rossi S; Sbaraglia M; Dell'Orto MC; Gasparotto D; Cacciatore M; Boscato E; Carraro V; Toffolatti L; Gallina G; Niero M; Pilozzi E; Mandolesi A; Sessa F; Sonzogni A; Mancini C; Mazzoleni G; Romeo S; Maestro R; Dei Tos AP
Oncotarget; 2016 May; 7(21):30109-18. PubMed ID: 27097112
[TBL] [Abstract][Full Text] [Related]
15. [The importance of mutational status in prognosis and therapy of GIST].
Comandone A; Boglione A
Recenti Prog Med; 2015 Jan; 106(1):17-22. PubMed ID: 25621775
[TBL] [Abstract][Full Text] [Related]
16. BRAF mutations in KIT/PDGFRA positive gastrointestinal stromal tumours (GISTs): Is their frequency underestimated?
Jašek K; Váňová B; Grendár M; Štanclová A; Szépe P; Hornáková A; Holubeková V; Plank L; Lasabová Z
Pathol Res Pract; 2020 Nov; 216(11):153171. PubMed ID: 32836055
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis.
Miettinen M; Lasota J
Arch Pathol Lab Med; 2006 Oct; 130(10):1466-78. PubMed ID: 17090188
[TBL] [Abstract][Full Text] [Related]
18. PDGFRA activating mutations in gastrointestinal stromal tumors.
Heinrich MC; Corless CL; Duensing A; McGreevey L; Chen CJ; Joseph N; Singer S; Griffith DJ; Haley A; Town A; Demetri GD; Fletcher CD; Fletcher JA
Science; 2003 Jan; 299(5607):708-10. PubMed ID: 12522257
[TBL] [Abstract][Full Text] [Related]
19. Extra-gastrointestinal stromal tumor arising in the lesser omentum with a platelet-derived growth factor receptor alpha (PDGFRA) mutation: a case report and literature review.
Kanamori K; Yamagata Y; Honma Y; Date K; Wada T; Hayashi T; Otsuki S; Sekine S; Yoshikawa T; Katai H; Nishida T
World J Surg Oncol; 2020 Jul; 18(1):183. PubMed ID: 32703220
[TBL] [Abstract][Full Text] [Related]
20. Malignancies associated with GIST: a retrospective study with molecular analysis of KIT and PDGFRA.
Mayr P; Märkl B; Agaimy A; Kriening B; Dintner S; Schenkirsch G; Schneider-Stock R
Langenbecks Arch Surg; 2019 Aug; 404(5):605-613. PubMed ID: 30877378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
